NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/18/2025
Back to search
Official data from USPTO
YOUR REBLOZYL CONNECTION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
02/18/2025
Classification
Registered
Trademark type
Combined
Nice classes
44
Filing date
04/21/2023
Registration date
02/18/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/18/2025
Last transaction
02/18/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/24/2023
First use in commerce
07/24/2023
Drawing code
3
Owner type
03
Owner location
Princeton, NJ
Examiner
MARTIN, LIEF
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words "YOUR REBLOZYL CONNECTION" with three dots between "REBLOZYL" and "CONNECTION".
Holders and representatives
Holders
C. C. (pessoa física)
C. C. (pessoa física)
Representatives
Marilyn F. Kelly BRISTOL-MYERS SQUIBB COMPANY
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Health care servicesproviding information to physicianshealth care professionals and patients on the topic of health issues and health awareness in the fields of oncologyimmunologyinflammationMyelodysplastic syndromes (MDS) and anemia; providing a website featuring educational information related to healthcare and health awareness in the fields of oncologyimmunologyinflammationMyelodysplastic syndromes (MDS) and anemia
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/18/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/29/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/29/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/03/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/03/2025
IUAF
USE AMENDMENT FILED
10/16/2024
EISU
TEAS STATEMENT OF USE RECEIVED
10/16/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/15/2024
EX1G
SOU EXTENSION 1 GRANTED
10/15/2024
EXT1
SOU EXTENSION 1 FILED
10/15/2024
EEXT
SOU TEAS EXTENSION RECEIVED
10/15/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/23/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/04/2024
PUBO
PUBLISHED FOR OPPOSITION
02/27/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/23/2024
DOCK
ASSIGNED TO EXAMINER
01/18/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/20/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/19/2023
NWAP
NEW APPLICATION ENTERED
04/25/2023
Continuous trademark protection
Get notified about every new filing that threatens YOUR REBLOZYL CONNECTION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.